Articles

1. Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy

   • Tianchen Guo
   • Junfen Xu

   REVIEW Open access 11 April 2024

   

2. In vivo manufacture and manipulation of CAR-T cells for better druggability

   • Rui Hou
   • Xiaoxue Zhang
   • Ming Shi

   REVIEW 09 April 2024

   

3. The role of circular RNA during the urological cancer metastasis: exploring regulatory mechanisms and potential therapeutic targets

   • Yan Xu
   • Zhipeng Gao
   • Yuyan Zhu

   Review 01 April 2024

   

4. Tumor-associated fibrosis: a unique mechanism promoting ovarian cancer metastasis and peritoneal dissemination

   • Hiroki Fujimoto
   • Masato Yoshihara
   • Hiroaki Kajiyama

   REVIEW Open access 28 March 2024

   

5. Glioblastoma stem cell metabolism and immunity

   • Joseph Hawly
   • Micaela G. Murcar
   • Mark E. Issa

   REVIEW 26 March 2024

   

6. OX40/OX40 ligand and its role in precision immune oncology

   • Bicky Thapa
   • Shumei Kato
   • Razelle Kurzrock

   REVIEW Open access 25 March 2024

   

7. Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics

   • Bandari BharathwajChetty
   • Anjana Sajeev
   • Ajaikumar B. Kunnumakkara

   REVIEW 22 March 2024 Pages: 321 - 362

   

8. Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance

   • Shabnam Malik
   • Mohammed Sikander
   • Subhash C. Chauhan

   REVIEW 18 March 2024

   

9. The fibro-adipogenic progenitor APOD+DCN+LUM+ cell population in aggressive carcinomas

   • Lingyi Cai
   • Mikhail G. Kolonin
   • Dimitris Anastassiou

   Comment Open access 11 March 2024

   

10. TFCP2 as a therapeutic nexus: unveiling molecular signatures in cancer

    • Neha Kaushik
    • Apurva Jaiswal
    • Nagendra Kumar Kaushik

    REVIEW 07 March 2024

    

11. Preface

    • Hifzur R Siddique
    • Ajaikumar B Kunnumakkara

    EditorialNotes 06 March 2024 Pages: 3 - 3

12. Lipid metabolism and its implications in tumor cell plasticity and drug resistance: what we learned thus far?

    • Ravichandran Vishwa
    • Bandari BharathwajChetty
    • Ajaikumar B. Kunnumakkara

    REVIEW 05 March 2024 Pages: 293 - 319

    

13. Survival mechanisms of circulating tumor cells and their implications for cancer treatment

    • Shuang Zhou
    • Huanji Xu
    • Feng Bi

    Review 04 March 2024

    

14. Epidemiology of nasopharyngeal carcinoma: current insights and future outlook

    • Zhi Yi Su
    • Pui Yan Siak
    • Shiau-Chuen Cheah

    REVIEW 02 March 2024

    

15. Biographies

    Announcement 13 April 2024 Pages: 1 - 2

    

16. Comprehensive assessment of TECENTRIQ® and OPDIVO®: analyzing immunotherapy indications withdrawn in triple-negative breast cancer and hepatocellular carcinoma

    • Ghazaal Roozitalab
    • Behnaz Abedi
    • Parham Jabbarzadeh Kaboli

    REVIEW 27 February 2024

    

17. Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation

    • Milad Ashrafizadeh
    • Wei Zhang
    • Aiming Qiu

    REVIEW 19 February 2024 Pages: 229 - 260

    

18. Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance

    • Gh Rasool Bhat
    • Itty Sethi
    • Ajaz A. Bhat

    REVIEW Open access 08 February 2024 Pages: 197 - 228

    

19. Clusterin: a marker and mediator of chemoresistance in colorectal cancer

    • Sara Hlavca
    • Wing Hei Chan
    • Helen E. Abud

    REVIEW Open access 06 February 2024 Pages: 379 - 391

    

20. Therapeutic importance and diagnostic function of circRNAs in urological cancers: from metastasis to drug resistance

    • Zhibin Zhang
    • Zhixu Gao
    • Rong Xing

    Review 22 January 2024

    

21. The impact of tumor microenvironment: unraveling the role of physical cues in breast cancer progression

    • Ayuba Akinpelu
    • Tosin Akinsipe
    • Panagiotis Mistriotis

    Review Open access 19 January 2024

    

22. Epigenetic reprogramming of T cells: unlocking new avenues for cancer immunotherapy

    • Vipin Singh
    • Sandhik Nandi
    • Chandrima Das

    REVIEW 18 January 2024 Pages: 175 - 195

    

23. Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response

    • Nasim Ebrahimi
    • Mahdokht Sadat Manavi
    • Qi Lu

    REVIEW 16 January 2024 Pages: 457 - 479

    

24. The emerging roles of histone demethylases in cancers

    • Dali Tong
    • Ying Tang
    • Peng Zhong

    ReviewPaper 16 January 2024

    

25. Deciphering cellular plasticity in pancreatic cancer for effective treatments

    • Md. Hafiz Uddin
    • Dingqiang Zhang
    • Asfar S. Azmi

    REVIEW 09 January 2024 Pages: 393 - 408

    

26. UCP2 and pancreatic cancer: conscious uncoupling for therapeutic effect

    • Emily G. Caggiano
    • Cullen M. Taniguchi

    Review Open access 09 January 2024

    

27. PRUNE1 and NME/NDPK family proteins influence energy metabolism and signaling in cancer metastases

    • Veronica Ferrucci
    • Santosh Lomada
    • Massimo Zollo

    REVIEW Open access 05 January 2024

    

28. Glucocorticoid receptor: a harmonizer of cellular plasticity in breast cancer—directs the road towards therapy resistance, metastatic progression and recurrence

    • Debanjan Thakur
    • Debomita Sengupta
    • Sutapa Mukherjee

    Review 03 January 2024 Pages: 481 - 499

    

29. Targeting the key players of phenotypic plasticity in cancer cells by phytochemicals

    • Sajad Fakhri
    • Seyed Zachariah Moradi
    • Anupam Bishayee

    REVIEW 03 January 2024 Pages: 261 - 292

    

30. Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments

    • Roya Abedizadeh
    • Fateme Majidi
    • Davood Sabour

    REVIEW 19 December 2023

    

31. Biography—Mathieu Boissan, Pharm.D., Ph.D

    Announcement 11 December 2023 Pages: 1055 - 1055

    

32. HOXA9 transcription factor is a double-edged sword: from development to cancer progression

    • U Sangeetha Shenoy
    • Divya Adiga
    • Raghu Radhakrishnan

    Review Open access 08 December 2023

    

33. Regulation and targeting of SREBP-1 in hepatocellular carcinoma

    • Fengting Su
    • Andreas Koeberle

    Review Open access 01 December 2023

    

34. Targeting vimentin: a multifaceted approach to combatting cancer metastasis and drug resistance

    • Aliye Tabatabaee
    • Behjat Nafari
    • Mina Mirian

    REVIEW 28 November 2023 Pages: 363 - 377

    

35. Metastasis suppressor genes and their role in the tumor microenvironment

    • Cristina Megino-Luque
    • Jose Javier Bravo-Cordero

    REVIEW 20 November 2023 Pages: 1147 - 1154

    

36. Tumor ablation induced anti-tumor immunity: destruction of the tumor in situ with the aim to evoke a robust anti-tumor immune response

    • Yona Keisari
    • Itzhak Kelson

    COMMENTARY Open access 11 November 2023 Pages: 1065 - 1068

37. From modulation of cellular plasticity to potentiation of therapeutic resistance: new and emerging roles of MYB transcription factors in human malignancies

    • Shashi Anand
    • Kunwar Somesh Vikramdeo
    • Ajay Pratap Singh

    REVIEW 10 November 2023 Pages: 409 - 421

    

38. Preface

    • Mathieu Boissan

    EditorialNotes 08 November 2023 Pages: 1069 - 1069

39. Clonal tracking in cancer and metastasis

    • Syed Mohammed Musheer Aalam
    • Long Viet Nguyen
    • Nagarajan Kannan

    Non-Thematic Review 01 November 2023

    

40. Targeting microRNAs as a promising anti-cancer therapeutic strategy against traffic-related air pollution-mediated lung cancer

    • Hamed Kazemi Shariat Panahi
    • Mona Dehhaghi
    • Meisam Tabatabaei

    Review 01 November 2023

    

41. Prospects of earthworm coelomic fluid as a potential therapeutic agent to treat cancer

    • Shafiul Haque
    • Arif Hussain
    • Marta Fiołka

    ReviewPaper 01 November 2023

    

42. Epigenetic regulation of breast cancer metastasis

    • Chitra Thakur
    • Yiran Qiu
    • Fei Chen

    Review 19 October 2023

    

43. Tissue-derived extracellular vesicles in cancer progression: mechanisms, roles, and potential applications

    • Ziyang Ye
    • Wenjie Chen
    • Jianyong Lei

    Review 18 October 2023

    

44. Cancer cell plasticity, stem cell factors, and therapy resistance: how are they linked?

    • Homa Fatma
    • Hifzur R. Siddique

    Review 05 October 2023 Pages: 423 - 440

    

45. Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review

    • Sajad Fakhri
    • Seyed Zachariah Moradi
    • Anupam Bishayee

    Review 04 October 2023 Pages: 501 - 574

    

46. Sam68 is a druggable vulnerability point in cancer stem cells

    • Amanda Mendes da Silva
    • Veronika Yevdokimova
    • Yannick D. Benoit

    Review Open access 04 October 2023 Pages: 441 - 456

    

47. Cell plasticity modulation by flavonoids in resistant breast carcinoma targeting the nuclear factor kappa B signaling

    • Peter Kubatka
    • Lenka Koklesova
    • Mehdi Shakibaei

    Review Open access 04 October 2023 Pages: 87 - 113

    

48. Epithelial-to-mesenchymal transition in cancer progression: unraveling the immunosuppressive module driving therapy resistance

    • Deepti Singh
    • Hifzur R. Siddique

    Review 30 September 2023 Pages: 155 - 173

    

49. B7-H3 at the crossroads between tumor plasticity and colorectal cancer progression: a potential target for therapeutic intervention

    • Elizabeth Varghese
    • Samson Mathews Samuel
    • Dietrich Büsselberg

    REVIEW Open access 28 September 2023 Pages: 115 - 133

    

50. Metastasis suppressor genes in clinical practice: are they druggable?

    • Irwin H. Gelman

    REVIEW 25 September 2023 Pages: 1169 - 1188